Open AccessRuxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still’s Disease
Author(s) -
Ofer Levy,
Arie Apel,
Hossam Alhdor,
Avraham Mizrachi,
Nancy AgmonLevin,
Maya KorenMichowitz,
Mirit Amit-Vazina
Publication year - 2023
Publication title -
european journal of rheumatology :/european journal of rheumatology
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2147-9720
pISSN - 2148-4279
DOI - 10.5152/eurjrheum.2022.21064
Subject(s) - macrophage activation syndrome , adult onset still's disease , medicine , ruxolitinib , anakinra , refractory (planetary science) , disease , tocilizumab , salvage therapy , complication , immunology , chemotherapy , bone marrow , physics , astrobiology , myelofibrosis